147 related articles for article (PubMed ID: 6883387)
21. Treatment of relapsed aggressive lymphomas: regimens with and without high-dose therapy and stem cell rescue.
Hagemeister FB
Cancer Chemother Pharmacol; 2002 May; 49 Suppl 1():S13-20. PubMed ID: 12042984
[TBL] [Abstract][Full Text] [Related]
22. Serum level of intercellular adhesion molecule-1 in children with malignant lymphoma.
Abdelrazik N; Fouda M; Zaghloul MH; Abbas D
Med Princ Pract; 2008; 17(3):233-8. PubMed ID: 18408393
[TBL] [Abstract][Full Text] [Related]
23. [Interrelationship of pseudouridine and transfer RNA metabolic disorders in thermal injury].
Salomatin VV; Efimenko GP; Kamilov FKh; Lifshits RI
Vopr Med Khim; 1977; 23(5):642-6. PubMed ID: 595499
[TBL] [Abstract][Full Text] [Related]
24. Relationship of urinary pseudouridine and 1-methyladenosine to activity of leukemia and lymphoma.
Itoh K; Konno T; Sasaki T; Ishiwata S; Ishida N; Misugaki M
Clin Chim Acta; 1992 Mar; 206(3):181-9. PubMed ID: 1606704
[TBL] [Abstract][Full Text] [Related]
25. Pseudouridine and beta-aminoisobutyric acid excretion in urine: diagnostic and prognostic value.
Kvist E; Sjølin KE
Scand J Urol Nephrol; 1990; 24(4):283-5. PubMed ID: 2274752
[TBL] [Abstract][Full Text] [Related]
26. [Excretion of normal and modified RNA catabolites and creatinine in the urine as a function of nutrition in children].
Schöch G; Heller-Schöch G; Müller J; Clemens P; Holtgrewe A; Heddrich M
Monatsschr Kinderheilkd; 1983 May; 131(5):259-63. PubMed ID: 6192333
[TBL] [Abstract][Full Text] [Related]
27. Treatment results of tonsillar lymphoma: a 10-year experience.
Mohammadianpanah M; Omidvai S; Mosalei A; Ahmadloo N
Ann Hematol; 2005 Apr; 84(4):223-6. PubMed ID: 15042316
[TBL] [Abstract][Full Text] [Related]
28. [Pseudouridine excretion in patients with chronic renal insufficiency and in persons with transplanted kidney under the effect of immunosuppression].
Viting TA
Urol Nefrol (Mosk); 1976; (5):55-9. PubMed ID: 793137
[No Abstract] [Full Text] [Related]
29. [Analysis of a modified urinary nucleoside in lung cancer patients].
Tamura S; Miyamoto T; Iwahashi N; Fujii J; Ueki N; Seno T; Yamamoto T; Amuro Y; Nabeshima K; Hada T
Nihon Kyobu Shikkan Gakkai Zasshi; 1984 Aug; 22(8):684-9. PubMed ID: 6513215
[No Abstract] [Full Text] [Related]
30. The urinary excretion of nucleosides of ribonucleic acid by patients with advanced cancer.
Waalkes TP; Gehrke CW; Zumwalt RW; Chang SY; Lakings DB; Tormey DC; Ahmann DL; Moertel CG
Cancer; 1975 Aug; 36(2):390-8. PubMed ID: 1157009
[TBL] [Abstract][Full Text] [Related]
31. Urinary excretion of pseudouridine in patients with hepatocellular carcinoma.
Tamura S; Amuro Y; Nakano T; Fujii J; Moriwaki Y; Yamamoto T; Hada T; Higashino K
Cancer; 1986 Apr; 57(8):1571-5. PubMed ID: 2418945
[TBL] [Abstract][Full Text] [Related]
32. Urinary hypoxanthine and pseudouridine as indicators of tumor development in mesothelioma-transplanted nude mice.
Buhl L; Dragsholt C; Svendsen P; Hage E; Buhl MR
Cancer Res; 1985 Mar; 45(3):1159-62. PubMed ID: 3838262
[TBL] [Abstract][Full Text] [Related]
33. [Non-Hodgkin's lymphoma: clinical symptoms, therapy and prognosis in 37 patients].
Skunca Z; Gverić-Krecak V; Dominis M; Planinc-Peraica A; Jaksić B
Acta Med Croatica; 2003; 57(4):261-7. PubMed ID: 14639859
[TBL] [Abstract][Full Text] [Related]
34. Correlations of pseudouridine in 8-hour and 24-hour urinary samples determined by high-performance liquid chromatography.
Sjølin KE
Urol Res; 1982; 10(5):245-8. PubMed ID: 7164220
[TBL] [Abstract][Full Text] [Related]
35. Labeling index as a prognostic marker in non-Hodgkin's lymphomas.
Costa A; Bonadonna G; Villa E; Valagussa P; Silvestrini R
J Natl Cancer Inst; 1981 Jan; 66(1):1-5. PubMed ID: 6935451
[TBL] [Abstract][Full Text] [Related]
36. Excretion of pseudouridine as an independent prognostic factor in renal cell carcinoma.
Rasmuson T; Björk GR; Hietala SO; Stenling R; Ljungberg B
Acta Oncol; 1991; 30(1):11-5. PubMed ID: 2009178
[TBL] [Abstract][Full Text] [Related]
37. Determination of the age dependency of the creatinine-related pseudouridine excretion in children's urine by high-performance liquid chromatography.
Assmann B; Haas HJ
J Chromatogr; 1988 Dec; 434(1):202-8. PubMed ID: 3243814
[No Abstract] [Full Text] [Related]
38. Clinical value of urinary and serum pseudouridine in diagnosis and monitoring of primary liver cancer.
Tu Z; Xu S; Wu M
Chin Med J (Engl); 1995 Mar; 108(3):204-8. PubMed ID: 7796629
[TBL] [Abstract][Full Text] [Related]
39. Primary breast non-Hodgkin's lymphoma: a large single center study of initial characteristics, natural history, and prognostic factors.
Validire P; Capovilla M; Asselain B; Kirova Y; Goudefroye R; Plancher C; Fourquet A; Zanni M; Gaulard P; Vincent-Salomon A; Decaudin D
Am J Hematol; 2009 Mar; 84(3):133-9. PubMed ID: 19199367
[TBL] [Abstract][Full Text] [Related]
40. [Nucleolar organizer as a marker of malignancy grade and prognosis of non-Hodgkin's malignant lymphoma].
Raĭkhlin NT; Bukaeva IA; Probatova NA; Smirnova EA; Tupitsyn NN; Sholokhova EN
Arkh Patol; 1996; 58(4):22-8. PubMed ID: 8967858
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
